Achieving better demand forecasts for - and better access to - critical medical technologies in the developing world requires collaboration and investment from all of the key stakeholders in the value chain for these products, and will benefit each of them in turn. The three specific recommendations developed by the Working Group are feasible in the near term, with relatively modest financial resources. While the broader global health community plays a critical role in advocating for the importance of taking forecasting seriously, coordinating information and sharing risk, success ultimately depends on the actions of donors, industry, national health programs, and those charged with generating demand forecasts.
Ideas to action: independent research for global prosperity